CCND1 and colonic neoplasm: Additional findings supporting this mechanism included reduced colon tumor formation in muscarinic agonist-treated mice lacking intestinal epithelial cell βPix expression and reduced MYC, CCND1 and PTGS2 gene and protein expression in colon adenocarcinomas resected from those mice (Cheng et al., 2023).